About miRecule
miRecule is a company based in Rockville (United States) founded in 2018 by Anthony Saleh. It operates as a HealthTech. miRecule has raised $5.45 million across 6 funding rounds from investors including ARE, HHS and University of Southern Maryland. The company has 8 employees as of December 31, 2022. miRecule offers products and services including RNA Therapeutics for Cancer and RNA Therapeutics for Muscular Dystrophy. miRecule operates in a competitive market with competitors including MiRagen, Rakuten Medical, ProQR Therapeutics, Prosensa and Cardior Pharmaceuticals, among others.
- Headquarter Rockville, United States
- Employees 8 as on 31 Dec, 2022
- Founders Anthony Saleh
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mirecule, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.45 M (USD)
in 6 rounds
-
Latest Funding Round
$863.71 K (USD), Grant
Sep 18, 2024
-
Investors
ARE
& 8 more
-
Employee Count
8
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of miRecule
miRecule offers a comprehensive portfolio of products and services, including RNA Therapeutics for Cancer and RNA Therapeutics for Muscular Dystrophy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
RNA therapies are developed for cancer treatment solutions.
RNA therapies are created for muscular dystrophy treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of miRecule
miRecule has successfully raised a total of $5.45M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $863.71 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $863,708
-
First Round
First Round
(05 Nov 2019)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - miRecule | Valuation |
investors |
|
| Sep, 2021 | Amount | Grant - miRecule | Valuation |
investors |
|
| May, 2021 | Amount | Grant - miRecule | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in miRecule
miRecule has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include ARE, HHS and University of Southern Maryland. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on healthcare and life sciences.
|
Founded Year | Domain | Location | |
|
Pathway Bioventures is focused on seed-stage investments in precision therapeutics.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by miRecule
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - miRecule
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mirecule Comparisons
Competitors of miRecule
miRecule operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiRagen, Rakuten Medical, ProQR Therapeutics, Prosensa and Cardior Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Photoimmunotherapy platform for precision cancer treatment is developed.
|
|
| domain | founded_year | HQ Location |
RNA-based therapeutics are developed for genetic retinal disorders.
|
|
| domain | founded_year | HQ Location |
RNA-modulating therapeutics for neuromuscular disorders were developed.
|
|
| domain | founded_year | HQ Location |
Non-coding RNA therapeutics are developed for cardiovascular disease treatment.
|
|
| domain | founded_year | HQ Location |
Oligonucleotide therapies for neuromuscular diseases like Myotonic Dystrophy are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mirecule
Frequently Asked Questions about miRecule
When was miRecule founded?
miRecule was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is miRecule located?
miRecule is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Who is the current CEO of miRecule?
Anthony Saleh is the current CEO of miRecule. They have also founded this company.
Is miRecule a funded company?
miRecule is a funded company, having raised a total of $5.45M across 6 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Nov 05, 2019.
How many employees does miRecule have?
As of Dec 31, 2022, the latest employee count at miRecule is 8.
What does miRecule do?
miRecule, a biotechnology company, is engaged in the development of RNA therapies targeting cancer and muscular dystrophy. Innovative approaches are utilized through the proprietary DREAmiR platform, where genomic patient data is analyzed to create tailored therapeutics addressing genetic abnormalities. Solutions are being developed for neuromuscular diseases and rare genetic disorders in collaboration with partners like Sanofi. The focus is placed on creating first-in-class antibody RNA conjugate-based therapeutics to improve patient outcomes across critical health sectors.
Who are the top competitors of miRecule?
miRecule's top competitors include Exicure, Rakuten Medical and ProQR Therapeutics.
What products or services does miRecule offer?
miRecule offers RNA Therapeutics for Cancer and RNA Therapeutics for Muscular Dystrophy.
Who are miRecule's investors?
miRecule has 9 investors. Key investors include ARE, HHS, University of Southern Maryland, NIH SBIR/STTR, and Boutique Venture Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.